Velarion · Company Intelligence
Compensation Brief
Fiscal year 2023 · Filings through 2024-10-08

Aktis Oncology (AKTS)

Former CEO Jeffrey Shealy was paid $1,290,740 in fiscal year 2023 (SEC filing 0001213900-24-086050 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$1,290,740
Jeffrey Shealy total, FY2023
—
CEO pay percentile vs peers
—
CEO-to-median pay ratio
74.59%
Say-on-pay support, latest vote

You have just read Aktis Oncology's Summary Compensation Table. The whole free brief as a PDF, sent in 2 minutes, with every figure cited — then a few short notes on the deeper AKTS reports.

We send the PDF within 2 minutes, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Jeffrey Shealy (Former Chief Executive Officer), FY2023 total compensation $1,290,740 (base salary $470,730) [exec_comp, SEC accession 0001213900-24-086050, filed 2024-10-08]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

01

Summary Compensation Table — fiscal year 2023

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Jeffrey Shealy$470,730$0$571,500$0$235,365$0$13,145$1,290,740
Former Chief Executive Officer
David Aichele258,3080439,350077,493012,721787,872
Former EVP of Business Development
Kenneth Boller246,9890364,350061,747012,850685,936
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2023 totalFY2022 totalFY2021 totalΔ FY2022→2023
Jeffrey Shealy$1,290,740———
David Aichele787,872———
Kenneth Boller685,936———

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

How we handle your data → Privacy

Companies that benchmark against AKTS
1 company names AKTS as a compensation peer

Each company listed discloses AKTS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named AKTS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2023 total
David AicheleEVP$787,872
Jeffrey ShealyCEO$1,290,740
Kenneth BollerCFO$685,936
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2023 total
Arthur E. GeissIndependent Director$81,395
J. Michael McGuireIndependent Director$70,006
Jeffrey K. McMahonIndependent Director$65,604
Jerry D. NealIndependent Director$105,428
Jill K. FrizzleyIndependent Director—
Kamran S. CheemaDirector—
Matthew R. KahnIndependent Director—
Michelle L. PetockIndependent Director$86,900
Steven P. DenBaarsIndependent Director$68,003
Suzanne B. RudyIndependent Director$90,756
02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

03

Grants of plan-based awards — fiscal year 2023

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Jeffrey ShealyRSU2023-09-26——40,000—$129,600
David AichelePSU2023-09-13——60,000—7,800
David AicheleRSU2023-09-13——40,000—90,000
Kenneth BollerRSU2023-09-13——40,000—90,000
Kenneth BollerPSU2023-09-13——60,000—7,800
Jeffrey ShealyPSU2023-09-26——120,000—15,600
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Jeffrey Shealy$129,600$15,600$010.7%
David Aichele90,0007,80008.0%
Kenneth Boller90,0007,80008.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2023

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Kenneth BollerRSU40,000—$5,268
Kenneth BollerRSU3,000—395
Jeffrey ShealyRSU20,000—2,634
Jeffrey ShealyRSU30,000—3,951
Kenneth BollerRSU6,000—790
Kenneth BollerRSU4,000—527
Kenneth BollerRSU60,000—7,800
Kenneth BollerRSU9,000—1,185
David AicheleOption16,0008.11—
Jeffrey ShealyRSU120,000—15,600
Jeffrey ShealyRSU80,000—10,536
Jeffrey ShealyRSU6,000—790
Kenneth BollerOption9,0005.88—
David AicheleRSU60,000—7,800
Jeffrey ShealyOption20,0008.11—
Jeffrey ShealyRSU50,000—6,585
David AicheleRSU4,000—527
Jeffrey ShealyOption30,00010.15—
David AicheleRSU40,000—5,269
Jeffrey ShealyRSU40,000—5,268
Kenneth BollerRSU20,000—2,634
Kenneth BollerRSU35,000—4,608
David AicheleRSU28,000—3,688
David AicheleRSU15,000—1,976
David AicheleRSU10,000—1,317
Jeffrey ShealyOption6,0007.98—
Kenneth BollerOption10,0008.11—
Kenneth BollerOption15,0009.99—
David AicheleOption24,0009.99—
05

Incentive-plan design — the Compensation Discussion & Analysis

The Company's executive compensation program is designed to attract, motivate and retain its executive officers, who are critical to its success.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultantPearl Meyer & Partners
Clawback policy—
Anti-hedging—
Anti-pledging—
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20232023-11-0222,016,5777,499,406548,37274.59%Passed
20222022-11-1018,675,1695,331,822151,26677.79%Passed
20212021-10-2820,589,023822,008416,62296.16%Passed
20202020-10-2911,904,797937,870256,77792.7%Passed
20192019-11-0412,338,0402,021,16197,13085.92%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20232023-11-0274.59%a
20222022-11-1077.79%b
20212021-10-2896.16%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2023

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Jerry D. NealIndependent · Audit · Compensation (Chair) · Nominating (Chair) · IT Governance$31,437$73,991———$105,428
Suzanne B. RudyIndependent27,06263,694———90,756
Michelle L. PetockIndependent23,125063,775——86,900
Arthur E. GeissIndependent · Technology (Chair) · IT Governance (Chair)081,395———81,395
J. Michael McGuireIndependent20,87549,131———70,006
Steven P. DenBaarsIndependent · Technology · IT Governance19,12522,50626,372—068,003
Jeffrey K. McMahonIndependent19,56246,042———65,604
Kamran S. CheemaEmployee director—————0
Matthew R. KahnIndependent · Audit (Chair) · Compensation · Nominating00———0
Jill K. FrizzleyIndependent · Audit · Compensation · Nominating00———0
09

Board fee structure and ownership guideline

Annual cash retainer$140,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)30,000 / 11,000 / 10,000
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2023
Cash retainers and fees$141,186
Equity awards (grant-date value)$336,759
All other compensation$0
Total cost of the board$477,945

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Aktis Oncology2023Jeffrey Shealy$470,730$571,500$0$235,365$1,290,740

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10d

Frequently asked questions

Who was the highest-paid executive at Aktis Oncology in fiscal 2023?
As disclosed, Jeffrey Shealy (Former Chief Executive Officer) was the highest-paid executive at Aktis Oncology in fiscal 2023, with total compensation of $1,290,740.
How did shareholders vote on Aktis Oncology's executive compensation?
As disclosed, 74.59% of shareholders supported Aktis Oncology's executive compensation in the latest say-on-pay vote.
How much does Aktis Oncology spend in total on board compensation for fiscal 2023?
As disclosed, Aktis Oncology reported total board compensation of $477,945 for fiscal 2023.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Jeffrey ShealyDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation”. As printed: 1,290,740. View filing ↗
2Section 01, David AicheleDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation”. As printed: 787,872. View filing ↗
3Section 01, Kenneth BollerDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation”. As printed: 685,936. View filing ↗
4Section 03, Jeffrey Shealy RSUDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
5Section 03, David Aichele PSUDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
6Section 03, David Aichele RSUDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
7Section 03, Kenneth Boller RSUDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
8Section 03, Kenneth Boller PSUDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
9Section 03, Jeffrey Shealy PSUDEF 14A2024-10-080001213900-24-086050Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
10Section 08, Jerry D. NealDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 105,428. View filing ↗
11Section 08, Suzanne B. RudyDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 90,756. View filing ↗
12Section 08, Michelle L. PetockDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 86,900. View filing ↗
13Section 08, Arthur E. GeissDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 81,395. View filing ↗
14Section 08, J. Michael McGuireDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 70,006. View filing ↗
15Section 08, Steven P. DenBaarsDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 68,003. View filing ↗
16Section 08, Jeffrey K. McMahonDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 65,604. View filing ↗
17Section 08, Kamran S. CheemaDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 0. View filing ↗
18Section 08, Matthew R. KahnDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 0. View filing ↗
19Section 08, Jill K. FrizzleyDEF 14A2024-10-080001213900-24-086050Section “Director Compensation”. As printed: 0. View filing ↗
20Section 06, 2023 voteForm 8-K2023-11-020001213900-23-082841Item 5.07 · say-on-pay result. As reported: 74.59% (votes for as printed: 22,016,577). View filing ↗
21Section 06, 2022 voteForm 8-K2022-11-140001213900-22-071558Item 5.07 · say-on-pay result. As reported: 77.79% (votes for as printed: 18,675,169). View filing ↗
22Section 06, 2021 voteForm 8-K2021-11-010001213900-21-055652Item 5.07 · say-on-pay result. As reported: 96.16% (votes for as printed: 20,589,023). View filing ↗
23Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
24Section 09b board cost (computed)Computed——Cash 141,186 + equity 336,759 + all other 0 = 477,945, summed across the director compensation table rows.
25Aktis Oncology (subject), Section 10b CEO totalDEF 14A2024-10-080001213900-24-086050CEO total compensation as printed in Aktis Oncology's own proxy. As printed: 1,290,740. View filing ↗